BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32866234)

  • 1. Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study.
    Jenks JD; Prattes J; Frank J; Spiess B; Mehta SR; Boch T; Buchheidt D; Hoenigl M
    Clin Infect Dis; 2021 Oct; 73(7):e1737-e1744. PubMed ID: 32866234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
    Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
    Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
    Alhan O; Saba R; Akalin EH; Ener B; Ture Yuce Z; Deveci B; Guncu MM; Kahveci HN; Yilmaz AF; Odabasi Z
    Mycopathologia; 2023 Oct; 188(5):643-653. PubMed ID: 37273172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study.
    Autier B; Prattes J; White PL; Valerio M; Machado M; Price J; Egger M; Gangneux JP; Hoenigl M
    J Clin Microbiol; 2022 Jan; 60(1):e0168921. PubMed ID: 34643415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Euroimmun Aspergillus Antigen ELISA for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid.
    Egger M; Penziner S; Dichtl K; Gornicec M; Kriegl L; Krause R; Khong E; Mehta S; Vargas M; Gianella S; Porrachia M; Jenks JD; Venkataraman I; Hoenigl M
    J Clin Microbiol; 2022 Apr; 60(4):e0021522. PubMed ID: 35350844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
    Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
    Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
    Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: A retrospective two-centre study.
    Scharmann U; Verhasselt HL; Kirchhoff L; Buer J; Rath PM; Steinmann J; Ziegler K
    Mycoses; 2020 Dec; 63(12):1362-1367. PubMed ID: 32885514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the sōna
    Jani K; McMillen T; Morjaria S; Babady NE
    J Clin Microbiol; 2021 Aug; 59(9):e0059821. PubMed ID: 34232067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage.
    Jenks JD; Mehta SR; Taplitz R; Aslam S; Reed SL; Hoenigl M
    Mycoses; 2019 Mar; 62(3):230-236. PubMed ID: 30565352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Aspergillus galactomannan lateral flow assay with a digital reader for the diagnosis of invasive aspergillosis: a multicenter study.
    Guo J; Xiao C; Tian W; Lv L; Hu L; Ni L; Wang D; Li W; Qiao D; Wu W
    Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):249-257. PubMed ID: 38030860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of
    Linder KA; Kauffman CA; Miceli MH
    J Fungi (Basel); 2020 Nov; 6(4):. PubMed ID: 33217952
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis.
    Cao XJ; Li YP; Xie LM; Zhang HL; Qin YS; Guo XG
    Biomed Res Int; 2020; 2020():5434589. PubMed ID: 33335924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.
    Eigl S; Prattes J; Reinwald M; Thornton CR; Reischies F; Spiess B; Neumeister P; Zollner-Schwetz I; Raggam RB; Flick H; Buchheidt D; Krause R; Hoenigl M
    Int J Antimicrob Agents; 2015 Oct; 46(4):401-5. PubMed ID: 26187363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
    Prattes J; Lackner M; Eigl S; Reischies F; Raggam RB; Koidl C; Flick H; Wurm R; Palfner M; Wölfler A; Neumeister P; Thornton CR; Krause R; Lass-Flörl C; Hoenigl M
    Mycoses; 2015 Aug; 58(8):461-9. PubMed ID: 26103209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different lateral flow assays on bronchoalveolar lavage fluid for invasive aspergillosis screening in non-hematological patients.
    Devillers E; Scherer E; Navellou JC; Grenouillet F; Millon L; Bellanger AP
    J Mycol Med; 2024 Jun; 34(2):101481. PubMed ID: 38718721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the JF5-based Aspergillus galactomannoprotein lateral flow device for diagnosing invasive aspergillosis in cancer patients.
    Wan L; Cai X; Ling M; Kan J; Yin M; Wang H
    Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1221-1229. PubMed ID: 38625450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.
    Zhou W; Li H; Zhang Y; Huang M; He Q; Li P; Zhang F; Shi Y; Su X
    J Clin Microbiol; 2017 Jul; 55(7):2153-2161. PubMed ID: 28446576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
    Ghazanfari M; Yazdani Charati J; Davoodi L; Arastehfar A; Moazeni M; Abastabar M; Haghani I; Mayahi S; Hoenigl M; Pan W; Hedayati MT
    Mycoses; 2022 Oct; 65(10):960-968. PubMed ID: 35979737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.